Tempus
Resolving brand mentions across new media
Tempus
Resolving brand mentions across new media
Tempus
Arcmira media summary
Browse Tempus interviews, podcasts & event videos — 2 indexed from ARK Invest & Bessemer Venture Partners, updated May 2025.
Precision medicine company cited for its V2 diagnostics approach combining molecular and phenotypic data.
Cited as a successful example of a company using multimodal data in oncology.
Arcmira tracks 2 indexed media appearances or mentions for Tempus, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "Mapping The Brain: The Future Of Neuroscience With Dr. Jin Hyung Lee" with transcript-derived context and links when available.
Tempus is connected to Healthcare Reimbursement and CPT Codes, Multimodal AI in Medicine, Multiomics in Arcmira's media graph.
2
Mentions
4.6K
Views
The trendline is visible, but the dated evidence behind Tempus is in the premium layer.

“Precision medicine company cited for its V2 diagnostics approach combining molecular and phenotypic data.”

“Cited as a successful example of a company using multimodal data in oncology.”